MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Oncogene

• Publication date

  2008-06-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/onc.2008.6PMID 18246122
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases.

  2007cited by this paper
• Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway.

  2007cited by this paper
• Selective inhibition of PED protein expression sensitizes B‐cell chronic lymphocytic leukaemia cells to TRAIL‐induced apoptosis

  2007cited by this paper
• The promise of TRAIL—potential and risks of a novel anticancer therapy

  2007cited by this paper
• CpG island hypermethylation of tumor suppressor microRNAs in human cancer.

  2007cited by this paper
• Regulation of the p27Kip1 tumor suppressor by miR‐221 and miR‐222 promotes cancer cell proliferation

  2007cited by this paper
• TRAIL: a multifunctional cytokine.

  2007cited by this paper
• TRAIL signalling: decisions between life and death.

  2007cited by this paper
• mir-29 regulates Mcl-1 protein expression and apoptosis

  2007cited by this paper
• miR-221 and miR-222 Expression Affects the Proliferation Potential of Human Prostate Carcinoma Cell Lines by Targeting p27Kip1*

  2007cited by this paper
• Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation.

  2007cited by this paper
• MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas.

  2007cited by this paper
• Extensive post-transcriptional regulation of microRNAs and its implications for cancer.

  2006cited by this paper
• Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: relationship to Bcl-2 family and caspase activation

  2006cited by this paper
• The clinical trail of TRAIL.

  2006cited by this paper
• Genomics of microRNA.

  2006cited by this paper
• How to decrease p27Kip1 levels during tumor development.

  2006cited by this paper
• Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells.

  2006cited by this paper
• MicroRNAs modulate the angiogenic properties of HUVECs.

  2006cited by this paper
• MicroRNA signatures in human cancers

  2006cited by this paper
• MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies

  2005cited by this paper
• Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis

  2005cited by this paper
• The role of microRNA genes in papillary thyroid carcinoma.

  2005cited by this paper
• MicroRNA expression profiles classify human cancers

  2005cited by this paper
• c-Myc-regulated microRNAs modulate E2F1 expression

  2005cited by this paper
• A microRNA polycistron as a potential human oncogene

  2005cited by this paper
• PED mediates AKT-dependent chemoresistance in human breast cancer cells.

  2005cited by this paper
• Accumulation of miR-155 and BIC RNA in human B cell lymphomas.

  2005cited by this paper
• siRNA and miRNA: an insight into RISCs.

  2005cited by this paper
• RAS is regulated by the let-7 microRNA family.

  2005cited by this paper
• MicroRNA biogenesis: drosha can't cut it without a partner.

  2005cited by this paper
• Targeting Apoptosis Pathways in Cancer Therapy

  2005cited by this paper
• How microRNAs control cell division, differentiation and death.

  2005cited by this paper
• Cold stress-induced protein Rbm3 binds 60S ribosomal subunits, alters microRNA levels, and enhances global protein synthesis.

  2005cited by this paper
• MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation.

  2005cited by this paper
• Regulation of miRNA expression during neural cell specification

  2005cited by this paper
• The role of apoptosis in cancer development and treatment response

  2005cited by this paper
• miR-15 and miR-16 induce apoptosis by targeting BCL2.

  2005cited by this paper
• A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.

  2005cited by this paper
• Post-transcriptional gene silencing by siRNAs and miRNAs.

  2005cited by this paper
• Intensified Cloning Efforts Have Revealed Numer

  2004cited by this paper
• An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues.

  2004cited by this paper
• Review Cell Death: Critical Control Points Another Line of Evidence for the Importance of Caspases in Cell Death Came From

  2004cited by this paper
• Detection of Overexpressed and Phosphorylated Wild-Type Kit Receptor in Surgical Specimens of Small Cell Lung Cancer

  2004cited by this paper
• MicroRNA precursors in motion: exportin-5 mediates their nuclear export.

  2004cited by this paper
• The human DiGeorge syndrome critical region gene 8 and Its D. melanogaster homolog are required for miRNA biogenesis.

  2004cited by this paper
• Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation

  2004cited by this paper
• MicroRNAs and the regulation of cell death.

  2004cited by this paper
• A pancreatic islet-specific microRNA regulates insulin secretion

  2004cited by this paper
• MicroRNAs Modulate Hematopoietic Lineage Differentiation

  2004cited by this paper
• Transcription and processing of human microRNA precursors.

  2004cited by this paper
• Imatinib mesylate (Gleevec/Glivec) a molecular‐targeted therapy for chronic myeloid leukaemia and other malignancies

  2004cited by this paper
• p27 as a target for cancer therapeutics.

  2003cited by this paper
• Rapamycin specifically interferes with GM-CSF signaling in human dendritic cells, leading to apoptosis via increased p27KIP1 expression.

  2003cited by this paper
• The microRNA world: small is mighty.

  2003cited by this paper
• New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment?

  2003cited by this paper
• The Drosophila microRNA Mir-14 suppresses cell death and is required for normal fat metabolism.

  2003cited by this paper
• Gene silencing in cancer in association with promoter hypermethylation.

  2003cited by this paper
• MicroRNAs: deviants no longer.

  2002cited by this paper
• Death and anti-death: tumour resistance to apoptosis

  2002cited by this paper
• Apoptosis A Link between Cancer Genetics and Chemotherapy

  2002cited by this paper
• Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

  2002cited by this paper
• CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future

  2002cited by this paper
• ReviewPathways of Apoptosis in Lymphocyte Development , Homeostasis , and Disease

  2002cited by this paper
• The mitochondrial apoptosome: a killer unleashed by the cytochrome seas.

  2001cited by this paper
• Apoptosis and cancer chemotherapy.

  2001cited by this paper
• Low expression of p27 and low proliferation index do not correlate in hairy cell leukaemia

  2000cited by this paper
• p27KIP1: androgen regulation and prognostic significance in prostate cancer.

  2000cited by this paper
• The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems.

  2000cited by this paper
• Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.

  2000cited by this paper
• Therapeutic applications of apoptosis research.

  2000cited by this paper
• Induction of apoptosis by cancer chemotherapy.

  2000cited by this paper
• Mechanisms of apoptosis avoidance in cancer.

  1999cited by this paper
• CDK inhibitors: positive and negative regulators of G1-phase progression.

  1999cited by this paper
• Apoptosis and therapy

  1999cited by this paper
• Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo

  1999cited by this paper
• Apoptosis and drug response.

  1999cited by this paper
• Caspase-induced proteolysis of the cyclin-dependent kinase inhibitor p27Kip1 mediates its anti-apoptotic activity

  1999cited by this paper
• Apoptosis, p53, and tumor cell sensitivity to anticancer agents.

  1999cited by this paper
• Mammalian caspases: structure, activation, substrates, and functions during apoptosis.

  1999cited by this paper
• Biochemical pathways of caspase activation during apoptosis.

  1999cited by this paper
• Proteases to die for.

  1998cited by this paper
• A recombinant adenovirus expressing p27Kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells

  1997cited by this paper
• Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27.

  1997cited by this paper
• Translational Control of p27Kip1 Accumulation During the Cell Cycle

  1996cited by this paper
• Impact of the cyclin–dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents

  1996cited by this paper
• p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors.

  1995cited by this paper

• Epigenetich Mechanisms Involved in the Etiology of Lung Cancers: From Noncoding RNAs to Exosomal Noncoding RNAs.

  2025cites this paper
• Current Evidence Supporting the Role of miRNA as a Biomarker for Lung Cancer Diagnosis Through Exhaled Breath Condensate Collection: A Narrative Review

  2025cites this paper
• Obatoclax enhances TRAIL-induced apoptosis in non-small-cell-lung-cancer cells by increasing TRAIL receptor expression, priming for mitochondrial apoptosis and reducing XIAP levels

  2025cites this paper
• Top 100 most-cited articles on apoptosis of non-small cell lung cancer over the past two decades: a bibliometrics analysis

  2025cites this paper
• Significance of TRAIL/Apo-2 ligand and its death receptors in apoptosis and necroptosis signalling: Implications for cancer-targeted therapeutics.

  2024cites this paper
• Dysregulation of different modes of programmed cell death by epigenetic modifications and their role in cancer.

  2024cites this paper
• Differential Expression of miR-192, miR-221, miR-15 Among the Nodule Tissues of Sarcoidosis and Lung Cancer

  2024cites this paper
• Potential role of saffron and its components on miRNA levels in various disorders, a comprehensive review

  2023cites this paper
• MiR-590-5p promotes cisplatin resistance via targeting hMSH2 in ovarian cancer

  2023cites this paper
• microRNAs in exhaled breath condensate for diagnosis of lung cancer in a resource-limited setting: a concise review

  2023cites this paper
• MicroRNAs as Potential Biomarkers of Environmental Exposure to Polycyclic Aromatic Hydrocarbons and Their Link with Inflammation and Lung Cancer

  2023cites this paper
• The Small RNA Landscape in NSCLC: Current Therapeutic Applications and Progresses

  2023cites this paper
• The predictive value of MiR-221 in cancer chemoresistance: a systematic review and meta-analysis

  2023cites this paper
• Relationship between the microRNAs and PI3K/AKT/mTOR axis: Focus on non-small cell lung cancer.

  2022cites this paper
• Decreased cell proliferation and induced apoptosis in human B-chronic lymphocytic leukemia following miR-221 inhibition through modulation of p27 expression

  2022cites this paper
• Correction: MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer

  2022cites this paper
• Cell cycle associated miRNAs as target and therapeutics in lung cancer treatment

  2022cites this paper
• Exosomal microRNAs and long noncoding RNAs: Novel mediators of drug resistance in lung cancer

  2022cites this paper
• Pt(IV) Prodrug as a Potential Antitumor Agent with APE1 Inhibitory Activity.

  2022cites this paper
• β-Glucan: A dual regulator of apoptosis and cell proliferation.

  2021cites this paper
• MiRNAs as Anti-Angiogenic Adjuvant Therapy in Cancer: Synopsis and Potential

  2021cites this paper
• Cotargeting of miR‐126‐3p and miR‐221‐3p inhibits PIK3R2 and PTEN, reducing lung cancer growth and metastasis by blocking AKT and CXCR4 signalling

  2021cites this paper
• miR-26b enhances the sensitivity of hepatocellular carcinoma to Doxorubicin via USP9X-dependent degradation of p53 and regulation of autophagy

  2021cites this paper
• Review for "Co‐targeting of miR‐126‐3p and miR‐221‐3p inhibits PIK3R2 and PTEN, reducing lung cancer growth and metastasis by blocking AKT and CXCR4 signaling"

  2021cites this paper
• Role of microRNAs in response to cadmium chloride in pancreatic ductal adenocarcinoma

  2021cites this paper
• MicroRNAs and Long Non-coding RNAs in c-Met-Regulated Cancers

  2020cites this paper
• MicroRNAs: potential biomarkers for diagnosis and prognosis of different cancers

  2020cites this paper
• Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats

  2020cites this paper
• MiR-129-5p sensitization of lung cancer cells to etoposide-induced apoptosis by reducing YWHAB

  2020cites this paper
• Noncoding RNAs: the shot callers in tumor immune escape

  2020cites this paper
• Placental exosomes isolated from urine of patients with gestational diabetes exhibit a differential profile expression of microRNAs across gestation

  2020cites this paper
• Advances of exosome isolation techniques in lung cancer

  2020cites this paper
• Targeting Epigenetics in Lung Cancer.

  2020cites this paper
• Serum MiRNA as Predictive and Prognosis Biomarker in Advanced Stage Non-small Cell Lung Cancer in Indonesia

  2020cites this paper
• Emerging roles of microRNAs as a regulator in the progression of lung cancer and their implications in its diagnosis and therapy

  2019cites this paper
• A Cell’s Fate: An Overview of the Molecular Biology and Genetics of Apoptosis

  2019cites this paper
• MicroRNA-663 antagonizes apoptosis antagonizing transcription factor to induce apoptosis in epithelial cells

  2019cites this paper
• miR-221-3p promotes the cell growth of non-small cell lung cancer by targeting p27

  2019cites this paper
• Non-Coding RNAs and Cancer Gianpiero Di Leva and Michela Garofalo

  2019cites this paper
• Two different mechanisms of two different non-coding RNAs—MicroRNAs and PIWI-interacting RNAs: From origin to cancer

  2019cites this paper
• Progesterone up-regulates p27 through an increased binding of the progesterone receptor-A-p53 protein complex onto the non-canonical p53 binding motif in HUVEC.

  2019cites this paper
• Phytochemicals as Epigenetic Modifiers for Cancer Management With Special Reference to Lung Cancer

  2019cites this paper
• MicroRNA regulation of TRAIL mediated signaling in different cancers: Control of micro steering wheels during the journey from bench-top to the bedside.

  2019cites this paper
• Inhibition of MicroRNA-381 Promotes Tumor Cell Growth and Chemoresistance in Clear-Cell Renal Cell Carcinoma

  2019cites this paper
• MicroRNAs in cancer cell death pathways: Apoptosis and necroptosis.

  2019cites this paper
• Effects of ebv‐miR‐BART7 on tumorigenicity, metastasis, and TRAIL sensitivity of non‐small cell lung cancer

  2019cites this paper
• Research progress on the relationship between lung cancer drug-resistance and microRNAs

  2019cites this paper
• MicroRNA-221 and MicroRNA-222 in Common Human Cancers: Expression, Function, and Triggering of Tumor Progression as a Key Modulator.

  2019cites this paper
• Role of miRNA in Lung Cancer-Potential Biomarkers and Therapies.

  2018cites this paper
• Serum MicroRNA Signature Predicts Response to High-Dose Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer.

  2018cites this paper
• miR-26a/HOXC9 Dysregulation Promotes Metastasis and Stem Cell-Like Phenotype of Gastric Cancer

  2018cites this paper
• Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells

  2018cites this paper
• miRNAs as biomarkers and for the early detection of non-small cell lung cancer (NSCLC).

  2018cites this paper
• CHARACTERIZING THE ROLE OF MIRNA IN CANCER WITH SPECIAL REFERENCE TO BREAST CANCER, LUNG CANCER AND COLORECTAL CANCER

  2018cites this paper
• Upregulated miR-221/222 promotes cell proliferation and invasion and is associated with invasive features in retinoblastoma

  2018cites this paper
• Clinical significance of blood-based miRNAs as biomarkers of non-small cell lung cancer.

  2018cites this paper
• Bioinformatics in MicroRNA Research

  2017cites this paper
• Serum microRNA Signature Predicts Response to High-dose Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer

  2017cites this paper
• Exosomes in lung cancer liquid biopsies: Two sides of the same coin?

  2017cites this paper
• Identification of miRNA-7 by genome-wide analysis as a critical sensitizer for TRAIL-induced apoptosis in glioblastoma cells

  2017cites this paper
• MiR-222 in Cardiovascular Diseases: Physiology and Pathology

  2017cites this paper
• Downregulation of miR-33a-5p in Hepatocellular Carcinoma: A Possible Mechanism for Chemotherapy Resistance

  2017cites this paper
• Macrophage‐derived apoptotic bodies promote the proliferation of the recipient cells via shuttling microRNA‐221/222

  2017cites this paper
• High miRNA-221 expression is associated with poor overall survival in patients with non-small cell lung cancer

  2017cites this paper
• miR-221 inhibits autophagy and targets TP53INP1 in colorectal cancer cells.

  2017cites this paper
• Post-transcriptional regulation of mPGES-1 by the balance between CUGBP1 and miR-574-5p

  2017cites this paper
• Direct determination of small RNAs using a biotinylated polythiophene impedimetric genosensor.

  2017cites this paper
• Critical issues in the clinical application of liquid biopsy in non-small cell lung cancer.

  2017cites this paper
• Major Tumor Suppressor and Oncogenic Non-Coding RNAs: Clinical Relevance in Lung Cancer

  2017influential citation
• miR-133a Promotes TRAIL Resistance in Glioblastoma via Suppressing Death Receptor 5 and Activating NF-κB Signaling

  2017cites this paper
• MicroRNAs in DNA Damage Response, Carcinogenesis, and Chemoresistance.

  2017cites this paper
• Resistance to cancer chemotherapeutic drugs is determined by pivotal microRNA regulators.

  2017cites this paper
• miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives

  2017cites this paper
• Role of phytochemicals in the modulation of miRNA expression in cancer.

  2017cites this paper
• MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer

  2017cites this paper
• Wound fluids affect miR-21, miR-155 and miR-221 expression in breast cancer cell lines, and this effect is partially abrogated by intraoperative radiation therapy treatment

  2017cites this paper
• Expression of MicroRNAs in Thyroid Carcinoma.

  2017cites this paper
• Withdrawn: The effects of MiR-223 on the sensitivity of non-small cell lung cancer cells to erlotinib and its underlying mechanisms

  2017cites this paper
• Downregulation of miR-222 Induces Apoptosis and Cellular Migration in Adenoid Cystic Carcinoma Cells.

  2017cites this paper
• The role of exosomes and miRNAs in drug‐resistance of cancer cells

  2017cites this paper
• MicroRNAs as regulators of apoptosis mechanisms in cancer

  2016cites this paper
• Serum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinoma

  2016cites this paper
• Intercellular transfer of small RNAs from astrocytes to lung tumor cells induces resistance to chemotherapy

  2016cites this paper
• Potential Role of TRAIL in Metastasis of Mutant KRAS Expressing Lung Adenocarcinoma

  2016cites this paper
• Effect of miRNAs in lung cancer suppression and oncogenesis

  2016cites this paper
• miR-223 enhances the sensitivity of non-small cell lung cancer cells to erlotinib by targeting the insulin-like growth factor-1 receptor

  2016cites this paper
• Innovative therapies based on the use of non-coding RNAs for non-small cell lung cancer (NSCLC)

  2016cites this paper
• The Landscape of Pancreatic Cancer Therapeutic Resistance Mechanisms

  2016cites this paper
• MicroRNA Profiles of Drug-Resistant Myeloma Cell Lines

  2016cites this paper
• MiRNA-221-3p desensitizes pancreatic cancer cells to 5-fluorouracil by targeting RB1

  2016cites this paper
• Role of microRNAs in inflammation-associated liver cancer

  2016cites this paper
• Mir-221/222 are promising targets for innovative anticancer therapy

  2016cites this paper
• TP53/MicroRNA Interplay in Hepatocellular Carcinoma

  2016cites this paper
• MicroRNA In Lung Cancer: Novel Biomarkers and Potential Tools for Treatment

  2016cites this paper
• miR‐222 attenuates cisplatin‐induced cell death by targeting the PPP2R2A/Akt/mTOR Axis in bladder cancer cells

  2016cites this paper
• A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis

  2016cites this paper
• Innovative therapeutic tools to prevent BM-MSC recruitment and activity into tumor microenvironment

  2016cites this paper
• Exosomal miRNA Analysis in Non-small Cell Lung Cancer (NSCLC) Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool.

  2016cites this paper
• Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice

  2016influential citation
• microRNA-221 Enhances MYCN via Targeting Nemo-like Kinase and Functions as an Oncogene Related to Poor Prognosis in Neuroblastoma

  2016cites this paper